MedTrace Logo

Recognizing Ventricular Fibrillation From an Area of a Mobile Phone

NCT01824212 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2016-03-23

No results posted yet for this study

Summary

Recognition of out of hospital cardiac arrest (OHCA) during an emergency call is based on standardized questions concerning the symptoms of OHCA. With this method cardiac arrest is recognized in 50-83% of cases. When the emergency medical dispatcher identifies cardiac arrest during the emergency call the survival of the patient improves. Accurate emergency medical service response is activated promptly and bystander will receive cardiopulmonary resuscitation (CPR) instructions. It has been estimated that proper implementation of CPR instructions will save thousands of lives each year.

If the ECG could be recorded by the mobile phone, transmitted during the emergency call to the dispatch centre and analysed there with the software of a semi-automated external defibrillator(AED), the recognition of cardiac arrest could be more accurate.

The aim of this study is to examine, if AED, with minimal size electrodes within an area of a mobile phone, is able to recognize reliably ventricular fibrillation (VF), the rhythm with the best prognosis in OHCA.

Conditions

  • Ventricular Fibrillation

Sponsors & Collaborators

  • Kuopio University Hospital

    collaborator OTHER

  • North Karelia Central Hospital

    lead OTHER

Principal Investigators

  • Helena Jäntti, MD, PhD · Kuopio University Hospital

  • Sakari Syväoja, MD · North Karelia Central Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01824212 on ClinicalTrials.gov